Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BIVV

Bioverativ

$50.76

-5.35 (-9.53%)

, RHHBY

Roche

$30.82

1.72 (5.91%)

18:08
11/20/17
11/20
18:08
11/20/17
18:08
Recommendations
Deutsche cuts Bioverativ target to $53 after positive Roche data »

Deutsche Bank analyst…

BIVV

Bioverativ

$50.76

-5.35 (-9.53%)

RHHBY

Roche

$30.82

1.72 (5.91%)

SHPG

Shire

$141.37

-6 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 09

    Dec

  • 23

    Dec

  • 23

    Feb

SHPG

Shire

$147.37

2.74 (1.89%)

, RHHBY

Roche

$29.10

0.205 (0.71%)

15:32
11/20/17
11/20
15:32
11/20/17
15:32
Recommendations
Shire, Roche analyst commentary at BTIG »

Shire selloff on Roche…

SHPG

Shire

$147.37

2.74 (1.89%)

RHHBY

Roche

$29.10

0.205 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

SHPG

Shire

$147.37

2.74 (1.89%)

, BIVV

Bioverativ

$56.11

0.82 (1.48%)

09:02
11/20/17
11/20
09:02
11/20/17
09:02
Hot Stocks
Shire, Bioverativ fall after Roche hemophilia A study hits goals »

Shares of Shire (SHPG)…

SHPG

Shire

$147.37

2.74 (1.89%)

BIVV

Bioverativ

$56.11

0.82 (1.48%)

RHHBY

Roche

$29.10

0.205 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 09

    Dec

  • 23

    Dec

  • 23

    Feb

AIMT

Aimmune

$34.95

-0.33 (-0.94%)

08:34
11/20/17
11/20
08:34
11/20/17
08:34
Initiation
Aimmune initiated at Roth Capital »

Aimmune initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AIMT

Aimmune

$34.95

-0.33 (-0.94%)

08:03
11/20/17
11/20
08:03
11/20/17
08:03
Hot Stocks
Aimmune to host investor symposium on AR101 peanut allergy treatment »

Aimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Thursday
SHPG

Shire

$140.03

0.76 (0.55%)

15:52
11/16/17
11/16
15:52
11/16/17
15:52
Hot Stocks
Shire treatment of pediatric UC patients granted FDA orphan status »

Shire's treatment of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHPG

Shire

$140.03

0.76 (0.55%)

, RHHBY

Roche

$28.73

-0.12 (-0.42%)

13:49
11/16/17
11/16
13:49
11/16/17
13:49
Recommendations
Shire, Roche analyst commentary at Cantor Fitzgerald »

Roche's black box…

SHPG

Shire

$140.03

0.76 (0.55%)

RHHBY

Roche

$28.73

-0.12 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

SHPG

Shire

$140.03

0.76 (0.55%)

, RHHBY

Roche

$28.73

-0.12 (-0.42%)

13:13
11/16/17
11/16
13:13
11/16/17
13:13
Recommendations
Shire, Roche, Bioverativ analyst commentary at RBC Capital »

Roche approval neutral to…

SHPG

Shire

$140.03

0.76 (0.55%)

RHHBY

Roche

$28.73

-0.12 (-0.42%)

BIVV

Bioverativ

$55.18

0.79 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 09

    Dec

  • 23

    Dec

  • 23

    Feb

REGN

Regeneron

$386.30

1.5 (0.39%)

, SNY

Sanofi

$44.66

0.01 (0.02%)

09:09
11/16/17
11/16
09:09
11/16/17
09:09
Recommendations
Regeneron, Sanofi analyst commentary at Evercore ISI »

Regeneron price target…

REGN

Regeneron

$386.30

1.5 (0.39%)

SNY

Sanofi

$44.66

0.01 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 09

    Dec

Wednesday
SHPG

Shire

$139.27

0.95 (0.69%)

09:23
11/15/17
11/15
09:23
11/15/17
09:23
Recommendations
Shire analyst commentary at Susquehanna »

Shire outlook remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.